Oncogene - Table of Contents alert Volume 35 Issue 20

If you are unable to see the message below, click here to view.

Advertisement Oncogenesis Focus Collection: Cancer & Metabolism While extremely diverse in origin, all cancer cells show profound metabolic changes. The articles in this Special Issue discuss the connection between cancer cells and their metabolic adaptations, from molecular mechanisms to anticancer therapies, and highlight the dialogue between whole organism and cancer cells. Explore the complete Special Issue in full.  TABLE OF CONTENTS Volume 35, Issue 20 (May 2016) In this issue Review Commentary Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogenesis Focus Collection: Cancer & Metabolism While extremely diverse in origin, all cancer cells show profound metabolic changes. The articles in this Special Issue discuss the connection between cancer cells and their metabolic adaptations, from molecular mechanisms to anticancer therapies, and highlight the dialogue between whole organism and cancer cells. Explore the complete Special Issue. Review Top Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy R Mandal, S Becker and K Strebhardt Oncogene 2016 35: 2547-2561; advance online publication, September 14, 2015; 10.1038/onc.2015.329 Abstract | Full Text Commentary Top Targeting tumor–stroma crosstalk: the example of the NT157 inhibitor T Rampias, R Favicchio, J Stebbing and G Giamas Oncogene 2016 35: 2562-2564; advance online publication, October 19, 2015; 10.1038/onc.2015.392 Abstract | Full Text Original Articles Top Negative regulation of RNA-binding protein HuR by tumor-suppressor ECRG2 C Lucchesi, M S Sheikh and Y Huang Oncogene 2016 35: 2565-2573; advance online publication, October 5, 2015; 10.1038/onc.2015.339 Abstract | Full Text RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma B A Wilky, C Kim, G McCarty, E A Montgomery, K Kammers, L R DeVine, R N Cole, V Raman and D M Loeb Oncogene 2016 35: 2574-2583; advance online publication, September 14, 2015; 10.1038/onc.2015.336 Abstract | Full Text Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells R Xing, L Li, L Chen, Z Gao, H Wang, W Li, J Cui, G Tian, Q Liang, J Yu, J J Sung, G Luo, H Gao, X Xu, H Yang, J Wang, X Zhang, J M Wang, J Huang, Y Yu, J Wang and Y Lu Oncogene 2016 35: 2584-2591; advance online publication, September 14, 2015; 10.1038/onc.2015.324 Abstract | Full Text ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4 M Pieraccioli, S Nicolai, A Antonov, J Somers, M Malewicz, G Melino and G Raschellà Oncogene 2016 35: 2592-2601; advance online publication, August 24, 2015; 10.1038/onc.2015.320 Abstract | Full Text Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth Y Schumacher, T Aparicio, S Ourabah, F Baraille, A Martin, P Wind, R Dentin, C Postic and S Guilmeau Oncogene 2016 35: 2602-2614; advance online publication, August 24, 2015; 10.1038/onc.2015.283 Abstract | Full Text Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma L Treps, S Edmond, E Harford-Wright, E M Galan-Moya, A Schmitt, S Azzi, A Citerne, N Bidère, D Ricard and J Gavard Oncogene 2016 35: 2615-2623; advance online publication, September 14, 2015; 10.1038/onc.2015.317 Abstract | Full Text Neddylation controls basal MKK7 kinase activity in breast cancer cells T Zhu, J Wang, Y Pei, Q Wang, Y Wu, G Qiu, D Zhang, M Lv, W Li and J Zhang Oncogene 2016 35: 2624-2633; advance online publication, September 14, 2015; 10.1038/onc.2015.323 Abstract | Full Text Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling E Sanchez-Lopez, E Flashner-Abramson, S Shalapour, Z Zhong, K Taniguchi, A Levitzki and M Karin Oncogene 2016 35: 2634-2644; advance online publication, September 14, 2015; 10.1038/onc.2015.326 Abstract | Full Text Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer S Das, S Rachagani, Y Sheinin, L M Smith, C B Gurumurthy, H K Roy and S K Batra Oncogene 2016 35: 2645-2654; advance online publication, September 14, 2015; 10.1038/onc.2015.327 Abstract | Full Text LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells OPEN Q Wei, Z-H Chen, L Wang, T Zhang, L Duan, C Behrens, I I Wistuba, J D Minna, B Gao, J-H Luo and Z P Liu Oncogene 2016 35: 2655-2663; advance online publication, September 14, 2015; 10.1038/onc.2015.328 Abstract | Full Text RUNX3 is a novel negative regulator of oncogenic TEAD–YAP complex in gastric cancer Y Qiao, S J Lin, Y Chen, D C-C Voon, F Zhu, L S H Chuang, T Wang, P Tan, S C Lee, K G Yeoh, M Sudol and Y Ito Oncogene 2016 35: 2664-2674; advance online publication, September 14, 2015; 10.1038/onc.2015.338 Abstract | Full Text Short Communication Top Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling E Flashner-Abramson, S Klein, G Mullin, E Shoshan, R Song, A Shir, Y Langut, M Bar-Eli, H Reuveni and A Levitzki Oncogene 2016 35: 2675-2680; advance online publication, June 29, 2015; 10.1038/onc.2015.229 Abstract | Full Text Advertisement View most cited articles - which ones have you missed? Take a look at what your colleagues have been citing across the Oncogene journal over the past two years.  Click here to visit special webpage Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.